Inflammatory neuropathies.
We discuss two of the most common of the acquired inflammatory neuropathies: Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy, as well as their variants. We review their clinical presentation, electrophysiologic findings, and management, highlighting knowledge gained from the recent literature. Unfortunately, although treatments exist for both Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy, none are completely curative and all have significant potential side effects and/or expense. Better understanding of the underlying pathophysiology of these diseases is needed in order to develop more targeted therapies.
Briemberg
Hannah R
HR
Department of Neurology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Amato
Anthony A
AA
D020275:Guillain-Barre Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy* / Q000503:physiopathology*